MagForce
$0
0
+$0+0% Friday 20:48
Statistics
Day High
0
Day Low
0
52W High
3.85
52W Low
0
Volume
39,169
Avg. Volume
939
Mkt Cap
74,829
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
29JunExpected
Q1 2020
Q3 2020
Q3 2020
Q4 2020
Q1 2021
Q3 2021
Q1 2022
-0.1
0.07
0.24
0.41
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MGFRF. It's not an investment recommendation.
About
Pharmaceuticals: Other
Health Technology
Pharmaceuticals: Major
MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of solid tumors; NanoPlan, a simulation software that helps the treating physicians to define the NanoTherm therapy schedule according to the distribution of the NanoTherm depots in the tumor; and NanoActivator, a magnetic field applicator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
Show more...
CEO
Dr. Benjamin J. Lipps
Employees
29
Country
UK
ISIN
DE000A0HGQF5
WKN
000A0HGQF